Generic Name: entacapone
Common side effects of Comtan include: urine discoloration.  See below for a comprehensive list of adverse effects.
Applies to entacapone: oral tablet
In addition to its needed effects, some unwanted effects may be caused by entacapone (the active ingredient contained in Comtan). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking entacapone:
Some of the side effects that can occur with entacapone may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to entacapone: oral tablet
Very common (10% or more): Dyskinesia (up to 27%), hyperkinesia (10%)Common (1% to 10%): Hypokinesia, dizziness, somnolence, taste perversion, aggravated parkinsonism, dystonia, headache, tremorFrequency not reported: Falling asleep during activities of daily livingPostmarketing reports: Neuroleptic malignant syndrome[Ref]
There were no cases of neuroleptic malignant syndrome during clinical trials.  Since market introduction, there have been isolated cases, especially following abrupt reduction or discontinuation of this drug and other concomitant dopaminergic drugs.[Ref]
Very common (10% or more): Nausea (up to 14%), diarrhea (up to 11%)Common (1% to 10%): Abdominal pain, constipation, vomiting, dry mouth, dyspepsia, flatulence, gastritis, gastrointestinal disordersVery rare (less than 0.01%): AnorexiaPostmarketing reports: Colitis[Ref]
In clinical trials, diarrhea occurred in approximately 10% of patients.  It was generally mild to moderate, but in 1.3% of people it was severe.  Upon discontinuation, diarrhea generally resolved.  There have been postmarketing reports of drug-induced microscopic colitis, primarily lymphocytic colitis.[Ref]
Very common (10% or more): Urine discoloration (10%)[Ref]
The most commonly reported adverse reactions included dyskinesia, urine discoloration, diarrhea, nausea, hyperkinesia, abdominal pain, vomiting, and dry mouth.[Ref]
Common (1% to 10%): DyspneaFrequency not reported: Pulmonary fibrosis[Ref]
Common (1% to 10%): Increased sweatingRare (less than 0.1%): Erythematous, maculopapular rashVery rare (less than 0.01%): UrticariaFrequency not reported: Skin hair, beard, and nail discolorations[Ref]
Common (1% to 10%): Back pain, falls, leg crampsPostmarketing reports: Rhabdomyolysis[Ref]
Isolated cases of rhabdomyolysis have occurred in patients treated with this drug.  The complicated nature of these cases makes it difficult to determine the role this drug may have had.  Rhabdomyolysis has been reported secondary to severe dyskinesias or neuroleptic malignant syndrome (NMS) in patients with Parkinson's disease.[Ref]
Common (1% to 10%): Anxiety, insomnia, hallucinations, confusion, paranoiaUncommon (0.1% to 1%): AgitationFrequency not reported: Impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating[Ref]
Common (1% to 10%): Purpura, decreased hemoglobin[Ref]
A clinically significant decrease in hemoglobin has been observed in 1.8% of patients.  The underlying mechanism may involve decreased absorption of iron from the gastrointestinal tract.[Ref]
Common (1% to 10%): Fatigue, asthenia, pain, vertigo[Ref]
The incidence of myocardial infarction and other ischemic heart disease events was 0.43% and 1.54%, respectively, in an analysis of 13 double-blind studies involving 2082 patients.[Ref]
Common (1% to 10%): Ischemic heart disease events other than myocardial infarction (e.g., angina pectoris, postural hypotensionUncommon (0.1% to 1%): Myocardial infarction[Ref]
Rare (less than 0.1%): Abnormal liver function testsPostmarketing reports: Hepatitis with mainly cholestatic features[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. "Product Information. Comtan (entacapone)" Novartis Pharmaceuticals, East Hanover, NJ. 
3. Cerner Multum,  Inc. "Australian Product Information." O 0
Not all side effects for Comtan may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Absence of or decrease in body movements
hyperactivity
increase in body movements
seeing, hearing, or feeling things that are not there
twisting
twitching
uncontrolled repetitive movements of the tongue, lips, face, arms, or legs


Cough or hoarseness
fever or chills
lower back or side pain
painful or difficult urination


Confusion
muscle cramps
pain
shortness of breath
stiffness
unusual tiredness or weakness


Abdominal or stomach pain
constipation
diarrhea
dizziness
nausea


Acid or sour stomach
anxiety
belching
bruising
burning feeling in the chest or stomach
difficult or labored breathing
dry mouth
heartburn
indigestion
irritability
loss of strength or energy
muscle pain or weakness
passing gas
restlessness
sleepiness or unusual drowsiness
small, red spots on the skin
stomach discomfort, upset, or tenderness
sweating increased
tightness in the chest
tremor
trouble sleeping
unusual or unpleasant (after) taste
unusual weak feeling

